Biotechnology

AstraZeneca paved the way for PARPs in prostate cancer when it won an approval for Lynparza in advanced patients. Now...

The biotech terminated a Phase 2 study after treatment led to serious liver enzyme elevations in multiple patients with...

Monitoring and measuring forest ecosystems are complex challenges because software, collection systems and computing...

Chroma Medicine, which launched last year with $125 million in funding, has drawn several high-profile biotech leaders to...

Cellarity is the second Flagship company in as many months to raise a Series C round instead of filing to go public.

The acquisition, Incyte’s first of an entire company, hands the pharmaceutical company a potentially long lasting treatment...

Oregon State University researchers have developed a new satellite tag that allows them to better track whales' behavior,...

The biotech said the proposed offer “significantly undervalues” the company, but that it’s open to considering a higher...

Shares in LogicBio had lost nearly all their value since a 2018 IPO, bringing the company to the brink of Nasdaq delisting....

Part of a $1 billion alliance the companies formed in 2020, the drug will be tested in a large study of patients who test...

A zoo once offered a coloring book featuring polar bears in winter scenes that came with crayons in various shades of...

The new cell-free protein crystallization (CFPC) method developed by Tokyo Tech includes direct protein crystallization and...

The regulator could soon approve medicines from Apellis, Gilead and GSK, as well as decide on whether to pull a...

Biophysicists from Skoltech, MIPT and their colleagues from the company Prostagnost have created a new technology for...

A newly published report by the HHS inspector general found that a substantial number of drugs given an accelerated...